1) Bettinelli A, Bianchetti MG, Lama G, et al. Use of calcium excretion values to distinguish two forms of primary renal tubular hypokalemic alkalosis: Bartter and Gitelman syndromes. J Pediatr. 1992; 120: 38-43
|
|
|
2) Simon DB, Hamdan JM, Lifton RP, et al. Bartter's syndrome, hypokalaemic alkalosis with hypercalciuria, is caused by mutations in the Na-K-2Cl cotransporter NKCC2. Nat Genet. 1996; 13: 183-8
|
|
|
3) Simon DB, Karet FE, Lifton RP, et al. Genetic heterogeneity of Bartter's syndrome revealed by mutations in the K+ channel, ROMK. Nat Genet. 1996; 14: 152-6
|
|
|
4) Simon DB, Nelson-Williams C, Lifton RP, et al. Gitelman's variant of Bartter's syndrome, inherited hypokalaemic alkalosis, is caused by mutations in the thiazide-sensitive Na-Cl cotransporter. Nat Genet. 1996; 12: 24-30
|
|
|
5) Simon DB, Bindra RS, Lifton RP, et al. Mutations in the chloride channel gene, CLCNKB, cause Bartter's syndrome type III. Nat Genet. 1997; 17: 171-8
|
|
|
6) Fukuyama S, Hiramatsu M, Ohta T, et al. Novel mutations of the chloride channel Kb gene in two Japanese patients clinically diagnosed as Bartter syndrome with hypocalciuria. J Clin Endocrinol Metab. 2004; 89: 5847-50
|
|
|
7) Jeck N, Konrad M, Seyberth HW, et al. Mutations in the chloride channel gene, CLCNKB, leading to a mixed Bartter-Gitelman phenotype. Pediatr Res. 2000; 48: 754-8
|
|
|
8) Zelikovic I, Szargel R, Nakhoul F, et al. A novel mutation in the chloride channel gene, CLCNKB, as a cause of Gitelman and Bartter syndromes. Kidney Int. 2003; 63: 24-32
|
|
|
9) 野津寛大, 飯島一誠, 松尾雅文. Batter症候群の病因病態: 遺伝子解析結果から見えてきたもの. 日本小児科学会雑誌. 2008; 112: 1059-67
|
|
|
10) Seyberth HW. An improved terminology and classification of Bartter-like syndromes. Nat Clin Pract Nephrol. 2008; 4: 560-7
|
|
|
11) Soupart A, Unger J, Decaux G, et al. Bartter's syndrome with a salt reabsorption defect in the cortical part of Henle's loop. Am J Nephrol. 1988; 8: 309-15
|
|
|
12) Colussi G, Rombolà G, Minetti L, et al. Pseudo-Bartter's syndrome from surreptitious diuretic intake: differential diagnosis with true Bartter's syndrome. Nephrol Dial Transplant. 1992; 7: 896-901
|
|
|
13) Tsukamoto T, Kobayashi T, Chihara K, et al. Possible discrimination of Gitelman's syndrome from Bartter's syndrome by renal clearance study: report of two cases. Am J Kidney Dis. 1995; 25: 637-41
|
|
|
14) Bülow B, Hagmar L, Erfurth EM, et al. Increased cerebrovascular mortality in patients with hypopituitarism. Clin Endocrinol. 1997; 46: 75-81
|
|
|
15) Igarashi T. Bartter's syndrome and related disorders. Kidney and Dialysis. 1999; 46: 221-5
|
|
|
16) Colussi G, Rombolà G, De Ferrari ME, et al. Abnormal reabsorption of Na+/CI- by the thiazide-inhibitable transporter of the distal convoluted tubule in Gitelman's syndrome. Am J Nephrol. 1997; 17: 103-11
|
|
|
17) Joo KW, Lee JW, Han JS, et al. Reduced urinary excretion of thiazide-sensitive Na-Cl cotransporter in Gitelman syndrome: preliminary data. Am J Kidney Dis. 2007; 50: 765-73
|
|
|
18) Yeum CH, Kim SW, Choi KC, et al. Attenuated renal excretion in response to thiazide diuretics in Gitelman's syndrome: a case report. J Korean Med Sci. 2002; 17: 567-70
|
|
|
19) Colussi G, Bettinelli A, Bianchetti MG, et al. Thiazide test for the diagnosis of renal tubular hypokalemic disorders. Clin J Am Soc Nephrol. 2007; 2: 454-60
|
|
|